Evidence map›Paper›PMID 38242927›Full record

ArticleScientific reports2024

Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19.

Lucas Scardua-Silva, Beatriz Amorim da Costa, Ítalo Karmann Aventurato, Rafael Batista Joao, Brunno Machado de Campos, Mariana Rabelo de Brito, José Flávio Bechelli, Leila Camila Santos Silva, Alan Ferreira Dos Santos, Marina Koutsodontis Machado Alvim and 17 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 5 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 5 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Central Nervous System Alterations in Individuals with Long COVID: A Systematic Review.Revista da Sociedade Brasileira de Medicina Tropical · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  8. Trial
  9. Article
  10. Cognition and Long COVID: a Review.Current neurology and neuroscience reports · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 2 institutions in 1 country.

Lucas Scardua-Silva *Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Beatriz Amorim da Costa *Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Ítalo Karmann Aventurato *Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Rafael Batista JoaoBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Brunno Machado de CamposBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Mariana Rabelo de BritoBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
José Flávio BechelliBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Leila Camila Santos SilvaBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Alan Ferreira Dos SantosBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Marina Koutsodontis Machado AlvimBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Guilherme Vieira Nunes LudwigBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Cristiane RochaBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Thierry Kaue Alves Silva SouzaBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Maria Julia MendesBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Takeshi WakuBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil.
Vinicius de Oliveira BoldriniAutoimmune Research Lab, Institute of Biology, University of Campinas, Campinas, Brazil.
Natália Silva BrunettiAutoimmune Research Lab, Institute of Biology, University of Campinas, Campinas, Brazil.
Sophia Nora BaptistaAutoimmune Research Lab, Institute of Biology, University of Campinas, Campinas, Brazil.
Gabriel da Silva SchmittDepartment of Neurology, Clinics Hospital, University of Campinas, Campinas, Brazil.
Jhulia Gabriela Duarte de SousaDepartment of Radiology, Clinics Hospital, University of Campinas, Campinas, Brazil.
Tânia Aparecida Marchiori de Oliveira CardosoDepartment of Neurology, Clinics Hospital, University of Campinas, Campinas, Brazil.
André Schwambach VieiraMolecular Genetics Laboratory, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Leonilda Maria Barbosa SantosAutoimmune Research Lab, Institute of Biology, University of Campinas, Campinas, Brazil.
Alessandro Dos Santos FariasAutoimmune Research Lab, Institute of Biology, University of Campinas, Campinas, Brazil.
Mateus Henrique NogueiraBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil. mateusnogueira.psi@gmail.com.
Fernando CendesBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil. fcendes@unicamp.br.
Clarissa Lin YasudaBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, Brazil. cyasuda@unicamp.br.
Universidade Estadual de Campinas (UNICAMP) · BRBrazilian Institute of Neuroscience and Neurotechnology · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil 403307/2021-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.505625/2020-00Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/03557-9Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/11457-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/233160Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/04032-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/09230-5
6 · The paper itself

Abstract

Although some studies have shown neuroimaging and neuropsychological alterations in post-COVID-19 patients, fewer combined neuroimaging and neuropsychology evaluations of individuals who presented a mild acute infection. Here we investigated cognitive dysfunction and brain changes in a group of mildly infected individuals. We conducted a cross-sectional study of 97 consecutive subjects (median age of 41 years) without current or history of psychiatric symptoms (including anxiety and depression) after a mild infection, with a median of 79 days (and mean of 97 days) after diagnosis of COVID-19. We performed semi-structured interviews, neurological examinations, 3T-MRI scans, and neuropsychological assessments. For MRI analyses, we included a group of non-infected 77 controls. The MRI study included white matter (WM) investigation with diffusion tensor images (DTI) and functional connectivity with resting-state functional MRI (RS-fMRI). The patients reported memory loss (36%), fatigue (31%) and headache (29%). The quantitative analyses confirmed symptoms of fatigue (83% of participants), excessive somnolence (35%), impaired phonemic verbal fluency (21%), impaired verbal categorical fluency (13%) and impaired logical memory immediate recall (16%). The WM analyses with DTI revealed higher axial diffusivity values in post-infected patients compared to controls. Compared to controls, there were no significant differences in the functional connectivity of the posterior cingulum cortex. There were no significant correlations between neuropsychological scores and neuroimaging features (including DTI and RS-fMRI). Our results suggest persistent cognitive impairment and subtle white matter abnormalities in individuals mildly infected without anxiety or depression symptoms. The longitudinal analyses will clarify whether these alterations are temporary or permanent.

Indexed as

Brain DiseasesCognitive DysfunctionCOVID-19White MatterAdultBrainCross-Sectional StudiesDiffusion Tensor ImagingFatigueHumansMemory Disorders

Identifiers

PMID38242927
PMCPMC10798999
OpenAlexW4391018454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.